These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 22006278)
1. Towards the generation of patient-specific patches for cardiac repair. Forte G; Pagliari S; Pagliari F; Ebara M; Di Nardo P; Aoyagi T Stem Cell Rev Rep; 2013 Jun; 9(3):313-25. PubMed ID: 22006278 [TBL] [Abstract][Full Text] [Related]
2. Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine. Roshanbinfar K; Esser TU; Engel FB Antioxid Redox Signal; 2021 Jul; 35(3):143-162. PubMed ID: 32993354 [No Abstract] [Full Text] [Related]
3. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. Zhang F; Pasumarthi KB BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754 [TBL] [Abstract][Full Text] [Related]
4. Stem cell engineering for treatment of heart diseases: potentials and challenges. Li SC; Wang L; Jiang H; Acevedo J; Chang AC; Loudon WG Cell Biol Int; 2009 Mar; 33(3):255-67. PubMed ID: 19084605 [TBL] [Abstract][Full Text] [Related]
5. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Behfar A; Hodgson DM; Zingman LV; Perez-Terzic C; Yamada S; Kane GC; Alekseev AE; Pucéat M; Terzic A Ann N Y Acad Sci; 2005 May; 1049():189-98. PubMed ID: 15965118 [TBL] [Abstract][Full Text] [Related]
6. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation. Oikonomopoulos A; Kitani T; Wu JC Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941 [TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal control of cell fate and cardiac differentiation. Davis ME Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5567-8. PubMed ID: 22255600 [TBL] [Abstract][Full Text] [Related]
14. Chemical Engineering of Cell Therapy for Heart Diseases. Li Z; Hu S; Cheng K Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198 [TBL] [Abstract][Full Text] [Related]
15. Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. Jackman CP; Ganapathi AM; Asfour H; Qian Y; Allen BW; Li Y; Bursac N Biomaterials; 2018 Mar; 159():48-58. PubMed ID: 29309993 [TBL] [Abstract][Full Text] [Related]
16. The Future of Direct Cardiac Reprogramming: Any López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756 [TBL] [Abstract][Full Text] [Related]
17. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation. Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729 [TBL] [Abstract][Full Text] [Related]
18. Chemical genetics and its potential in cardiac stem cell therapy. Vieira JM; Riley PR Br J Pharmacol; 2013 May; 169(2):318-27. PubMed ID: 22385148 [TBL] [Abstract][Full Text] [Related]
19. Cardiac stem cells and their roles in myocardial infarction. Hou J; Wang L; Jiang J; Zhou C; Guo T; Zheng S; Wang T Stem Cell Rev Rep; 2013 Jun; 9(3):326-38. PubMed ID: 23238707 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts. Gerbin KA; Yang X; Murry CE; Coulombe KL PLoS One; 2015; 10(7):e0131446. PubMed ID: 26161513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]